Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Precigen Inc (PGEN)  
$1.54 0.01 (0.65%) as of 4:30 Fri 6/21


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 178,600,000
Market Cap: 275.04(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8901 - $1.85
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 7.4
Insider 3/6 Months : 8
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 96,686 1,592,031 13,134,243
Total Buy Value $0 $136,327 $2,615,293 $22,822,494
Total People Bought 0 1 4 8
Total Buy Transactions 0 1 6 12
Total Shares Sold 0 96,686 455,706 505,706
Total Sell Value $0 $136,327 $650,097 $765,097
Total People Sold 0 1 6 6
Total Sell Transactions 0 1 21 22
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 689
  Page 24 of 28  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Frank Steven Director   –       •      –    2016-03-10 4 A $34.99 $59,973 D/D 1,714 8,941     -
   Kirk Randal J Chief Executive Officer   •       •       •   2016-02-29 4 A $29.67 $999,991 I/I 33,425 105,150     -
   Kirk Randal J Chief Executive Officer   •       •       •   2016-01-29 4 A $27.11 $999,977 I/I 36,372 78,187     -
   Krishnan Krish S Chief Operating Officer   •       –      –    2016-01-29 4 OE $6.88 $100,840 I/I 14,657 56,657     -
   Krishnan Suma SVP--Product Development   •       –      –    2016-01-29 4 OE $6.88 $100,840 D/D 14,657 56,657     -
   Krishnan Krish S Chief Operating Officer   •       –      –    2016-01-28 4 OE $6.88 $100,840 D/D 14,657 56,657     -
   Krishnan Suma SVP--Product Development   •       –      –    2016-01-28 4 OE $6.88 $100,840 I/I 14,657 56,657     -
   Kirk Randal J Chief Executive Officer   •       •       •   2015-12-31 4 A $30.15 $999,964 I/I 32,674 48,678     -
   Kirk Randal J Chief Executive Officer   •       •       •   2015-12-11 4 B $29.83 $3,715,801 I/I 124,475 6,608,167 2.64     -
   Sterling Rick L. Chief Financial Officer   •       –      –    2015-12-07 4 OE $29.68 $99,992 D/D 3,369 3,369     -
   Kirk Randal J Chief Executive Officer   •       •       •   2015-12-07 4 B $30.69 $7,289,642 I/I 237,525 6,483,692 2.64     -
   Krishnan Krish S Chief Operating Officer   •       –      –    2015-12-04 4 S $30.12 $27,111 D/D (900) 42,000     -
   Krishnan Suma SVP--Product Development   •       –      –    2015-12-04 4 S $30.12 $27,111 D/D (900) 42,000     -
   Reed Thomas D. Chief Science Officer   •       –      –    2015-12-03 4 A $1.29 $82,711 D/D 64,117 64,117     -
   Krishnan Krish S Chief Operating Officer   •       –      –    2015-12-02 4 S $35.91 $718,260 D/D (20,000) 42,900     -
   Krishnan Suma SVP--Product Development   •       –      –    2015-12-02 4 S $35.91 $718,260 D/D (20,000) 42,900     -
   Kirk Randal J Chief Executive Officer   •       •       •   2015-12-01 4 A $35.34 $999,987 I/I 28,145 22,637     -
   Kirk Randal J Chief Executive Officer   •       •       •   2015-12-01 4 GD $0.00 $0 I/I 200 4,856,971     -
   Liffman Joel D SVP, FinanceOfficer   •       –      –    2015-07-20 3 IO $0.00 $0 D/D 0 150,000     -
   Frost Gregory Ian SVP--Health Sector   •       –      –    2015-05-28 4 OE $22.77 $4,554,000 D/D 200,000 300,000     -
   Krishnan Krish S Chief Operating Officer   •       –      –    2015-05-18 4 OE $7.12 $299,040 I/I 42,000 42,000     -
   Krishnan Krish S Chief Operating Officer   •       –      –    2015-05-18 4 OE $7.12 $299,040 D/D 42,000 62,900     -
   Krishnan Suma SVP--Product Development   •       –      –    2015-05-18 4 OE $7.12 $299,040 I/I 42,000 42,000     -
   Krishnan Suma SVP--Product Development   •       –      –    2015-05-18 4 OE $7.12 $299,040 D/D 42,000 62,900     -
   Frank Steven Director   –       •      –    2015-03-12 4 A $47.48 $59,967 D/D 1,263 7,227     -
  689 Records found
  Previous  20  21  22  23  24  25  26  27  28   
  Page 24 of 28
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us